Daily Archives: November 6, 2010

Duro Extend Capsules for Men Side Effects: Good, Bad, or Dangerous?

Guys who are using Duro Extend Capsules for Men are being advised by the Food and Drug Administration to dump the drug because of its potentially dangerous side effects.

Why? According to the agency, Duro Extend Capsules — marketed as a “dietary supplement” as well as a “male enhancer” — contain an undeclared drug ingredient which could lower your blood pressure to dangerous levels.

From the FDA safety alert: “Lab analysis has found Duro Extend Capsules for Men to contain Sulfoaidenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction, making the product an unapproved drug. The analogue may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.”

Continue reading

Al Amal Stem Cell Treatment Center To Be Established

Al Amal Stem Cell Treatment Center To Be Established. The Al Amal Hospital in Doha, Qatar is setting up a stem cell transplant unit according to a report by The Peninsula. The center is expected to be established by the end of the year.

It is expected to “provide optimal care to patients in need of advanced techno-therapy and are unable to afford treatment abroad” according to a source at Hamad Medical Corporation (HMC).

Continue reading

Afinitor Approved by FDA for SEGA

Novartis’ cancer drug Afinitor has gained the approval of the U.S. Food and Drug Administration (FDA) to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder.

Afinitor (everolimus) was approved under the FDA’s accelerated approval program. This program allows patients to have an earlier access to the drug even while confirmatory clinical trials are still being conducted.

An FDA news release tells us more about a study involving 28 patients to test the safety and effectiveness of the drug in treating SEGA: Continue reading